North Central Cancer Treatment Group N0531: Phase II trial of weekly albumin-bound paclitaxel (ABI-007; Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer

Alvaro Moreno-Aspitia, Edith A. Perez

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'North Central Cancer Treatment Group N0531: Phase II trial of weekly albumin-bound paclitaxel (ABI-007; Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer'. Together they form a unique fingerprint.